These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16409444)

  • 1. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question.
    Levine M
    J Thromb Haemost; 2006 Jan; 4(1):16-8. PubMed ID: 16409444
    [No Abstract]   [Full Text] [Related]  

  • 2. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No.
    Agnelli G; Verso M
    J Thromb Haemost; 2006 Jan; 4(1):14-5. PubMed ID: 16409443
    [No Abstract]   [Full Text] [Related]  

  • 3. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups.
    Huisman MV
    J Thromb Haemost; 2006 Jan; 4(1):10-3. PubMed ID: 16409442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic prophylaxis and central venous catheters in onco-hematological patients].
    Iturbe T; De Gregorio MA; Serrablo A; Cornudella R
    Sangre (Barc); 1999 Dec; 44(6):491. PubMed ID: 10822767
    [No Abstract]   [Full Text] [Related]  

  • 5. Catheter-related thrombosis.
    Freytes CO
    Cancer Treat Res; 2009; 148():207-21. PubMed ID: 19377926
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for the management of occluded central venous access devices: safety considerations.
    Smith LH
    Clin J Oncol Nurs; 2008 Feb; 12(1):155-7. PubMed ID: 18258586
    [No Abstract]   [Full Text] [Related]  

  • 7. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
    Debourdeau P; Farge D; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Büller HR; Bounameaux H
    J Thromb Haemost; 2013 Jan; 11(1):71-80. PubMed ID: 23217208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter.
    Verso M; Agnelli G
    Thromb Haemost; 2008 Jul; 100(1):167-8. PubMed ID: 18612558
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing vascular access device occlusions, Part. 1.
    Hadaway LC
    Nursing; 2000 Jul; 30(7):20. PubMed ID: 10983093
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.
    Fagnani D; Franchi R; Porta C; Pugliese P; Borgonovo K; Bertolini A; Duro M; Ardizzoia A; Filipazzi V; Isa L; Vergani C; Milani M; Cimminiello C;
    Ann Oncol; 2007 Mar; 18(3):551-5. PubMed ID: 17158773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now].
    Jansson JH
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):1984-5. PubMed ID: 16044753
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of vena cava thrombosis during catheterization. Comparison of calciheparin and defibrotide].
    Grosso P; Martello L; Petrini PL; Massei R
    Minerva Anestesiol; 1989 Jun; 55(6):273-6. PubMed ID: 2694006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a need for antithrombotic prophylaxis during laparascopic surgery? Always.
    Rasmussen MS
    J Thromb Haemost; 2005 Feb; 3(2):210-1. PubMed ID: 15670018
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
    Magagnoli M; Castagna L; Masci G; Santoro A
    Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
    [No Abstract]   [Full Text] [Related]  

  • 15. Interventions for restoring patency of occluded central venous catheter lumens (Review).
    van Miert C; Hill R; Jones L
    Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
    [No Abstract]   [Full Text] [Related]  

  • 16. Are patients with cancer receiving adequate thromboprophylaxis? Results from FRONTLINE.
    Wolff RA
    Cancer Treat Rev; 2003 Jun; 29 Suppl 2():7-9. PubMed ID: 12887943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
    Fagnani D; Bertolini A; Catena L; Tomirotti M; Visini M; Alatri A; De Paoli A; Aondio GM; Milani M; Arpaia G; Cimminiello C; ; Franchi R; Porta C; Pugliese P; Borgonovo K; Duro M; Ardizzoia A; Filipazzi V; Isa L; Vergani C; Carpenedo M; Viale P
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):35-40. PubMed ID: 20523163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in childhood cancer.
    Allen GA; Bhat R
    Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
    [No Abstract]   [Full Text] [Related]  

  • 19. Central venous catheter-related thrombosis: a systematic review.
    Yacopetti N
    J Infus Nurs; 2008; 31(4):241-8. PubMed ID: 18641488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase lock-therapy for hemodialysis occluded central venous catheters.
    Li Cavoli G; Schillaci O; Zagarrigo C; Servillo F; Li Cavoli TV; Palmeri M; Rotolo U
    Blood Purif; 2015; 39(1-3):238. PubMed ID: 25823425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.